Eirion Therapeutics

About:

Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.

Website: http://www.eirionthera.com/

Top Investors: Gore Range Capital, Haohai Biological Technology, Kinled Holding

Description:

Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.

Total Funding Amount:

$40M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)eirionthera.com

Founders:

Jon Edelson

Number of Employees:

1-10

Last Funding Date:

2021-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai